1.
Indian Heart J
;
2007 Jul-Aug; 59(4): 311-5
Article
in English
| IMSEAR
| ID: sea-5922
ABSTRACT
Stroke prevention in atrial fibrillation presents a challenge for many clinicians. A considerable amount of research has gone into creating scoring systems that can accurately predict thromboembolic risk. Patients at low enough risk are best treated with aspirin, whereas higher-risk patients require anticoagulation with warfarin despite its shortcomings. Antithrombotic regimens for moderate-risk patients require careful consideration based on bleeding risk, age, and the ability to undergo frequent serum monitoring. Oral drugs may soon be available to replace warfarin. While this may simplify dosing and monitoring, it will still be necessary to weigh the risks and benefits of therapy.
Subject(s)
Age Factors , Algorithms , Anticoagulants/therapeutic use , Aspirin/therapeutic use , Atrial Fibrillation/complications , Clinical Trials as Topic , Humans , Platelet Aggregation Inhibitors/therapeutic use , Predictive Value of Tests , Risk Assessment , Risk Factors , Stroke/etiology , Warfarin/therapeutic use
2.
Indian Heart J
;
2007 May-Jun; 59(3): 207-10
Article
in English
| IMSEAR
| ID: sea-5114
3.
Indian Heart J
;
2002 May-Jun; 54(3): 312-20
Article
in English
| IMSEAR
| ID: sea-5983